synthetic proteins
Recently Published Documents


TOTAL DOCUMENTS

96
(FIVE YEARS 9)

H-INDEX

17
(FIVE YEARS 0)

2022 ◽  
Author(s):  
Enrique Canessa ◽  
Livio Tenze

Differences and correspondence regarding the intrinsic data organisation of complete delta and omicron genome sequences according to its progression along the nucleotide A,C,G,T bases position are analysed. We found a sort of 'ordered' to 'disordered' transition around the S-spike protein region in the curves obtained from finite alternating sum series having independently distributed terms associated with (0,1) binary indicators for the nucleotides. To uncover such underlying features of genome sequences may assist in the development of synthetic proteins.


2021 ◽  
Author(s):  
Trevor E. Randall ◽  
Kelly Eckartt ◽  
Sravya Kakumanu ◽  
Alexa Price-Whelan ◽  
Lars E. P. Dietrich ◽  
...  

Cyclic diguanylate (c-di-GMP) signal transduction systems provide bacteria the ability to sense changing cell status or environmental conditions and then execute suitable physiological and social behaviours in response. In this review, we provide a comprehensive census of the stimuli and receptors that are linked to modulation of intracellular c-di-GMP. Emerging evidence indicates that c-di-GMP networks sense light, surfaces, energy, redox potential, respiratory electron acceptors, temperature, and structurally diverse biotic and abiotic chemicals. Bioinformatic analysis of sensory domains in diguanylate cyclases and c-di-GMP-specific phosphodiesterases as well as the receptor complexes associated with them reveals that these functions are linked to a diverse repertoire of protein domain families. We describe the principles of stimulus perception learned from studying these modular sensory devices, illustrate how they are assembled in varied combinations with output domains, and summarize a system for classifying these sensor proteins based on their complexity. Biological information-processing via c-di-GMP signal transduction is not only fundamental to bacterial survival in dynamic environments, but also is being used to engineer gene expression circuitry and synthetic proteins with à la carte biochemical functionalities.


Author(s):  
Pavankumar Janardhan Bhandari ◽  
Mullapudi Mohan Reddy ◽  
Kasuladevu Jegannadha Rao ◽  
Britto S. Sandanaraj

2021 ◽  
Author(s):  
Koki Nakatsu ◽  
Hitoshi Murakami ◽  
Gosuke Hayashi ◽  
Akimitsu Okamoto

Strategies for one-pot peptide ligation enable chemists to access synthetic proteins at a high yield in a short time. Herein, we report a new one-pot multi-segments ligation strategy using N-terminal thiazolidine (Thz) peptide and a formaldehyde scavenger. Among our designed 2-aminobenzamide-based aldehyde scavengers, 2-amino-5-methoxy-N’,N’-dimethylbenzohydrazide showed a good ability to capture formaldehyde from Thz at pH 4.0. This scavenger had compatibility with the conditions of native chemical ligation at pH 7.5. Using this scavenger for a model peptide ligation system, we performed one-pot four-segment ligation at a high yield without significant side reactions.


2021 ◽  
Author(s):  
Koki Nakatsu ◽  
Hitoshi Murakami ◽  
Gosuke Hayashi ◽  
Akimitsu Okamoto

Strategies for one-pot peptide ligation enable chemists to access synthetic proteins at a high yield in a short time. Herein, we report a new one-pot multi-segments ligation strategy using N-terminal thiazolidine (Thz) peptide and a formaldehyde scavenger. Among our designed 2-aminobenzamide-based aldehyde scavengers, 2-amino-5-methoxy-N’,N’-dimethylbenzohydrazide showed a good ability to capture formaldehyde from Thz at pH 4.0. This scavenger had compatibility with the conditions of native chemical ligation at pH 7.5. Using this scavenger for a model peptide ligation system, we performed one-pot four-segment ligation at a high yield without significant side reactions.


Peptides ◽  
2021 ◽  
pp. 170583
Author(s):  
Catherine H. Schein ◽  
Corri B. Levine ◽  
Susan L.F. McLellan ◽  
Surendra S. Negi ◽  
Werner Braun ◽  
...  
Keyword(s):  

2020 ◽  
Vol 2020 ◽  
pp. 1-7
Author(s):  
Mujahed I. Mustafa ◽  
Abdelrahman H. Abdelmoneim ◽  
Eiman M. Mahmoud ◽  
Abdelrafie M. Makhawi

The novel coronavirus is not only causing respiratory problems, but it may also damage the heart, kidneys, liver, and other organs; in Wuhan, 14 to 30% of COVID-19 patients have lost their kidney function and now require either dialysis or kidney transplants. The novel coronavirus gains entry into humans by targeting the ACE2 receptor that found on lung cells, which destroy human lungs through cytokine storms, and this leads to hyperinflammation, forcing the immune cells to destroy healthy cells. This is why some COVID-19 patients need intensive care. The inflammatory chemicals released during COVID-19 infection cause the liver to produce proteins that defend the body from infections. However, these proteins can cause blood clotting, which can clog blood vessels in the heart and other organs; as a result, the organs are deprived of oxygen and nutrients which could ultimately lead to multiorgan failure and consequent progression to acute lung injury, acute respiratory distress syndrome, and often death. However, there are novel protein modification tools called the QTY code, which are similar in their structure to antibodies, which could provide a solution to excess cytokines. These synthetic proteins can be injected into the body to bind the excess cytokines created by the cytokine storm; this will eventually remove the excessive cytokines and inhibit the severe symptoms caused by the COVID-19 infection. In this review, we will focus on cytokine storm in COVID-19 patients, their impact on the body organs, and the potential treatment by QTY code-designed detergent-free chemokine receptors.


Sign in / Sign up

Export Citation Format

Share Document